Coya Therapeutics (COYA) Current Assets (2022 - 2025)
Coya Therapeutics (COYA) has disclosed Current Assets for 4 consecutive years, with $49.9 million as the latest value for Q4 2025.
- Quarterly Current Assets rose 12.71% to $49.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.9 million through Dec 2025, up 12.71% year-over-year, with the annual reading at $49.9 million for FY2025, 12.71% up from the prior year.
- Current Assets hit $49.9 million in Q4 2025 for Coya Therapeutics, up from $32.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $49.9 million in Q4 2025 to a low of $7.2 million in Q4 2022.
- Historically, Current Assets has averaged $31.0 million across 4 years, with a median of $35.5 million in 2024.
- Biggest five-year swings in Current Assets: skyrocketed 473.37% in 2023 and later dropped 16.19% in 2025.
- Year by year, Current Assets stood at $7.2 million in 2022, then surged by 473.37% to $41.2 million in 2023, then grew by 7.55% to $44.3 million in 2024, then rose by 12.71% to $49.9 million in 2025.
- Business Quant data shows Current Assets for COYA at $49.9 million in Q4 2025, $32.0 million in Q3 2025, and $33.4 million in Q2 2025.